GENERAL COUNSEL
Thu, Feb 15, 2024
Feb 15
exercised or converted securities in DAWN
2,962 shares @ $0.00
Increased holdings by +25.90%
Option Exercise
Sale tied to a same-time option exercise
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology